Siemens HealthCare and IMPAC Medical Systems announce partnership

Monday 3rd August 2009

Siemens HealthCare is expanding its portfolio for cancer therapy by partnering with IMPAC Medical Systems, Inc. (IMPAC). The partnership will include an extension of its software distribution agreement to 2016, as well as the MOSAIQÒ software to its oncology portfolio.

This partnership with IMPAC will offer Siemens customers access to IMPAC's latest innovative oncology information system (OIS) in addition to the radiation therapy systems from Siemens. Moreover, Siemens and IMPAC will work together to develop interfaces between MOSAIQ and IONTRIS, making it possible to use MOSAIQ with Siemens particle therapy solutions in the future.

Under the extended agreement, Siemens will offer the MOSAIQ software as its next generation OIS offering to LANTIS, the OIS currently sold by Siemens. Siemens LANTIS customers will then have the option of upgrading to MOSAIQ or continuing to utilise their LANTIS systems. Siemens will extend service support and application training for its customers to include MOSAIQ. MOSAIQ is an image-enabled electronic medical record for oncology that allows documentation of patient data, from diagnosis to therapy. Clinical images, lab results, and external documents can also be integrated. Support for additional business functions such as scheduling, invoicing, management reporting and analysis, among others, can also be implemented.

"We have maintained a very successful partnership with IMPAC since 1992 in the area of oncology information systems. In addition to cooperating on the development of interfaces for our systems for proton and electron radiation therapy, we are now working together in particle therapy. We are confident we will be able to offer our customers sustainable oncology systems which help them to optimise workflows and master the daily challenges of the hospital routine," said Holger Schmidt, CEO of Oncology Care Systems at Siemens HealthCare.

Jay Hoey, IMPAC president and CEO, said: "We are pleased to partner with Siemens and look forward to continuing a long and mutually beneficial relationship. We are certain MOSAIQ will assist clinicians to efficiently manage even the most demanding workflows in oncology enabling our customers to deliver the best possible patient care."

Siemens

Feedback

Have YOUR say.

Name:
Email:
Location:

We welcome all feedback. However, we cannot publish anonymous comments, so please supply your name and location. Your details will not be displayed if you so request. To protect privacy we never publish email addresses.